お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:質量分析の世界市場:成長、動向および予測
市場調査レポート
商品コード
391377

質量分析の世界市場:成長、動向および予測

Mass Spectrometry Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
質量分析の世界市場:成長、動向および予測
出版日: 2021年03月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

質量分析(MS)は、質量対電荷比と気相式イオンの存在度を測ることによって、サンプル内の化学品の量と種類を特定する分析化学技術です。質量分析市場は使用する技術またはプラットホームに基づいて分類され、シングル質量分析、ハイブリッドまたはタンデム質量分析、およびその他の質量分析法に分けられます。これらのセグメントの中でも、ハイブリッド質量分析は幅広く適用され、他のプラットホームと比較して最も高い市場占有率を誇ります。トリプル四重極、イオントラップ、Q-TOFとFT-MSを含むLC-MS技術における過去5年間の技術革新は、革命的で、研究者に以前にも増して市場需要に貢献する、はるかに詳細な情報を得るためのツールをもたらしています。

当レポートでは、世界の質量分析市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 救済策を研究する
  • 市場の定義
  • 数量単位
  • 基本通貨
  • レビューと予報期間の年
  • 調査の一般的な前提条件

第2章 調査方法

  • イントロダクション
  • 分析方法論
  • 計量経済学的予測モデル
  • 調査の前提条件

第3章 エグゼクティブサマリー

第4章 主要な推論

第5章 市場の概観および産業動向

  • 現在の市場シナリオ
  • 技術概要
  • 治療薬の新しい展開
  • 投資分析
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 競争度合
    • 代替品の脅威
    • 新規参入者の脅威

第6章 成長要因、阻害要因、機会および課題の分析(DROC)

  • 市場の成長要因
    • ライフサイエンス研究における政府支出の増加
    • 製薬業界における研究開発費の増加
    • 食品・飲料業界において高まる食品への関心
  • 市場の阻害要因
    • 設備のコスト
    • 熟練労働者の欠如
  • 市場機会
    • 水中の微量汚染物質のモニタリング
    • プロテオミクス
    • 機能ゲノミクス
  • 主な課題

第7章 市場セグメンテーション

  • 技術別
    • シングル質量分析
    • ハイブリッド質量分析
  • 製品別
    • 設備
    • 試薬および消耗品
    • サービス
  • アプリケーション別
    • 医薬品
    • バイオテクノロジー
    • 工業化学
    • 環境試験
    • 食品・飲料の試験
    • 医学研究

第10章 地域別市場:地域別シェアおよび予測

  • 北米
    • イントロダクション
    • 米国
    • カナダ
    • その他
  • 欧州
    • イントロダクション
    • フランス
    • 英国
    • ドイツ
    • スペイン
    • ロシア
    • イタリア
    • その他
  • アジア太平洋地域
    • イントロダクション
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • その他
  • 中東・アフリカ地域
    • イントロダクション
    • アラブ首長国連邦
    • サウジアラビア
    • イスラエル
    • その他のMEA諸国
  • 中南米
    • イントロダクション
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他

第11章 競合情勢

第12章 主要ベンダー

  • Agilent Technologies
  • Danaher Corporation
  • PerkinElmer Inc
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Waters Corporation
  • 株式会社島津製作所
  • Leco Corporation.
  • Dani Instruments S.P.A.

第13章 アナリストによる投資機会の見通し

第14章 市場の将来展望

第8章 付録

  • 略語
  • 参考文献
  • 免責事項
目次
Product Code: 49152

The mass spectrometry market registered a market size of USD 4,880 million in 2020 and expected to grow USD 7,301 million by 2026 with a CAGR of nearly 6.3% during the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.

It is one of the powerful tools used for the analyses of chemical and biological entities. In addition, high demand from the biotechnology and pharmaceutical industries due to COVID-19 are driving factors for mass spectrometry market. In 2020, in India, researchers at the Delhi-based Institute of Genomics and Integrative Biology (IGIB) and the National Centre for Disease Control (NCDC) have been able to detect novel coronavirus (COVID-19) with 95% sensitivity and 100% specificity with respect to RT-PCR using mass spectrometer.

According to the Organisation for Economic Co-operation and Development (OECD), in 2018, in Germany, approximately 3.13% of GDP was spent on research and development which was increased from 3.07% of GDP in 2017 and 2.94% of GDP in 2016, respectively. Increasing investment on research and development activities is expected to increase demand for mass spectrometer in the drug development, proteomics and pharmaceuticals and drives the market growth.

Furthermore, advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools has the potential to stimulate the usage of mass spectroscopy across drug development, pharmaceuticals, food safety testing, proteomics and other fields.

The demands of the life sciences applications have led to the improvement of mass spectrometry technologies. The mass spectrometry such as MALDI-ToF used as a clinical diagnostic platform utilising a highly advanced method of protein pattern recognition to diagnose diseases. Hence, with the increasing technological advancement, the market is expected to grow over the forecast period.

Key Market Trends

Triple Quadrupole (Tandem) is Expected to Hold Significant Market Share in the Type of Hybrid Mass Spectrometry

Currently the tandem mass spectrometry devices are among the most in-demand. Liquid chromatography-mass spectrometry (LC-MS/MS)-based approaches are considered reagent-free. The high sensitivity and specificity of mass spectrometry can overcome many limitations associated with immunoassays such as cross-reactivity and non-specific antibody binding.

There is a higher demand for triple quadrupole mass spectrometer because triple quadrupole mass spectrometr is considered one of the most high-end instruments and moreover, many labs across the world are adopting this instrument.

For instance, according to a research article by Malin Kallsten et al., published in Analytical and Bioanalytical Chemistry Journal 2019, there has been a trend in mass spectrometry based characterization of antibody-drug conjugates (ADCs) towards the use of high-resolving mass spectrometry for many of these analyses. Quadrupole mass spectrometers represent a viable alternative for the characterization of antibody-drug conjugates (ADCs) in early-stage drug development.

As per Patented Medicine Prices Review Board 2018 report, in 2018, total R&D spending by the pharmaceutical industry was around 0.89 billion Canadian dollars which was increased from 0.87 billion Canadian dollars in 2017. Thus, increasing R&D spending on pharmaceuticals is expected to rise demand for mass spectrometrs in near future.

Moreover, a United Kingdom biotech laboratory has used mass spectrometry for coronavirus testing. In April 2020, United Kingdom diagnostics firm, MAP Sciences announced the development of rapid test for the COVID-19 virus. This technology deploys mass spectrometry to spot proteins that are unique to COVID-19 and is targeting to deliver test results within 30 minutes. These advancements are expected to fuel the growth of the studied market.

North America is Expected to Hold Major Market Share Over the Forecast Period

The major factors driving the market growth in North America region include growing funding for research and government initiatives in the United States, widespread usage of mass spectrometry in the metabolomics and petroleum sector and presence of key market players.

The United States government spends a significant percentage of its GDP on R&D. According to a 2018 report published by the Organization for Economic Co-operation and Development (OECD), about 2.82% of the country's GDP was spent on R&D. In addition, in 2019, the research and development (R&D) expenditure of U.S. pharmaceutical industry was around USD 83 billion up from USD 79.6 billion in 2018 and USD 71.4 billion in 2017, respectively. Thus, increasing R&D activities increase demand for mass spectrometers and drives market growth.

Drug development is an expensive and lengthy process, and the failure rate is also high. Factors such as lengthy-time period, high failure rate and high cost are forcing researchers to look for newer technologies.

Additionally, mass spectroscopy is also being used in clinical laboratories to measure small sample volumes, with improved confidence across an expanding range of healthcare applications, from toxicology to personalized medicine.

As per a September 2020 article, published in Oxford Academics, states that in the United States, response to the coronavirus disease-19 pandemic has been hampered by inadequate testing resources. Therefore, technologies such as, matrix-assisted laser desorption/ionization combined with mass spectrometry (MALDI-MS) are used to provide faster and cheaper diagnosis, which may drive its demand, over the forecast period.

Competitive Landscape

The Mass Spectrometry Market is highly competitive. The leading players offer an expansive product portfolio for mass spectrometers and have a broad geographic presence. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancement
    • 4.2.2 Growing Concerns Over Food Safety
    • 4.2.3 Rising R&D Expenditure By Pharmaceutical Industry & Government Research Organizations
  • 4.3 Market Restraints
    • 4.3.1 High Cost Of Instrument
    • 4.3.2 Lack Of Skilled Technicians
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Hybrid Mass Spectrometry
      • 5.1.1.1 Triple Quadrupole (Tandem)
      • 5.1.1.2 Quadrupole TOF (Q-TOF)
      • 5.1.1.3 FTMS (Fourier Transform Mass Spectrometry)
    • 5.1.2 Single Mass Spectrometry
      • 5.1.2.1 ION Trap
      • 5.1.2.2 Quadrupole
      • 5.1.2.3 Time-of-Flight (TOF)
    • 5.1.3 Other Mass Spectrometry
  • 5.2 By Application
    • 5.2.1 Pharmaceuticals Industry
    • 5.2.2 Biotechnology Industry
    • 5.2.3 Chemical Industry
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Bruker Corporation
    • 6.1.3 Danaher Corporation
    • 6.1.4 MassTech
    • 6.1.5 Analytik Jena (Endress+Hauser)
    • 6.1.6 Perkin elmer Inc.
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Waters Corporation
    • 6.1.10 JEOL Ltd.
    • 6.1.11 FLIR Systems, Inc.
    • 6.1.12 MKS Instruments, Inc.
    • 6.1.13 Hiden Analytical
    • 6.1.14 DANI Instruments S.p.A.
    • 6.1.15 LECO Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.